Latest Stock Buy or Sell? Make More Informed Decisions!
Today, Reza Samahin, P. Eng, CFA and The Panic-Proof Portfolio (Stockchase Research) commented about whether NCSM-Q, AEM-T, CPAY-N, RMD-N, G-N, KSI-X, PI-Q, RKLB-Q, TXN-Q, AMD-Q, INTC-Q, TSLA-Q, NVDA-Q, TSM-N, MELI-Q, GOOG-Q, HOOD-Q, UBER-N, PLTR-Q are stocks to buy or sell.
- Page 2/2
- Next Page
Makes great chips. It's software, not hardware. Hasn't been able to deliver the ecosystem to handle AI workloads effectively or reliably. He'd be much more bullish if it could get its act together on this.
Not gained market share. Not even close to NVDA. Success with hyperscalers, but not with the average customer. Has taken data centre market share.
Well positioned for explosion in commercial space activity as launch costs come down. Launch business will have a new product later this year, a direct competitor for the mid-range Falcon 9 from SpaceX. The other 2/3 of their business involves space systems, which is building satellites for customers. No dividend.
Really likes the scrappy, technical, and resourceful CEO. Reminds him of Elon Musk in the early days.
Allows you to tag almost anything for pennies. For example, clothing or toys; also getting into food. Lets you quickly and cheaply do inventory. You can use it for returned items, loss prevention, and authentication of high-end items like handbags. No dividend.
AirTag is a different segment of the market, and much bigger and more expensive. Impinj tags are tiny, barely seen with the eye, and way cheaper. NXP is a competitor; but not only is Impinj technology superior, it also won an IP lawsuit against NXP. There will be Chinese competition, but he doesn't see it as a big deal in NA or Europe.
Rare to find a high-quality, small-cap tech company in Canada with good management. High growth. Grew ARR last quarter by 60%, very impressive. Valuation of 7x may seem high by Canadian standards, but not compared to US peers. Targeting regulated industries that need a validation solution. No dividend.
Has the majority of the big-pharma household names as customers. Delivered on what they said they would over the years. Still quite a bit to go. Selling to both new customers and current installed base, a very good sign. Likes the metrics, management, the market, customer base.
G is a top rated supplier of business outsourcing services worldwide — a steady and reliable business. We like that cash reserves are growing, while debt is retired and shares bought back. It trades at 17x earnings, 3.6x book and supports a respectable ROE of 22%. We recommend setting a stop-loss at $35, looking to achieve $59 — upside potential over 18%. Yield 0.7%
(Analysts’ price target is $58.56)RMD provides cloud based digital medical devices to assist with sleep and respiratory monitoring and treatment — a steady and reliable business model. It trades at 26x earnings and supports a respectable ROE of 25%. We like that cash reserves are growing, while debt is retired and shares bought back. We recommend setting a stop-loss at $190, looking to achieve $271 — upside potential of 22%. Yield 1.0%
(Analysts’ price target is $271.71)This Atlanta based company provides digital services to companies to assist with payment of travel expenses in the US, internationally and in Brazil. The company just made a major investment into establishing a platform in Europe, including cross-currency capability. Overall a geographically diversified steady business model. It trades at 25x earnings and supports a healthy 31% ROE. We recommend setting a stop-loss at $240, looking to achieve $416 — upside potential of 17%. Yield 0%
(Analysts’ price target is $415.71)
Stock's gone nowhere for over a decade -- lost leadership on manufacturing and on design. US administrations have been pushing manufacturing back to the US, which makes INTC interesting. New, very technically capable, CEO; this is encouraging, though nothing will happen immediately.